(Q47712314)

5 February 2018

title

The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. (English)

1 reference

5 February 2018

0 references

Michael Koenigsmann

1

1 reference

5 February 2018

Kathleen Jentsch-Ullrich

2

1 reference

5 February 2018

Martin Mohren

3

1 reference

5 February 2018

Elke Becker

4

1 reference

5 February 2018

Marcell Heim

5

1 reference

5 February 2018

Astrid Franke

6

1 reference

5 February 2018

publication date

1 May 2004

1 reference

5 February 2018

published in

Transfusion

1 reference

5 February 2018

volume

44

1 reference

5 February 2018

issue

5

1 reference

5 February 2018

page(s)

777-784

1 reference

5 February 2018

Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

The whys and hows of hematopoietic progenitor and stem cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: comparison with patients at diagnosis and impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Automated enumeration of CD34+ cells in peripheral blood and bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Transplanted peripheral blood stem cells, mobilized by chemotherapy alone, can induce persistent hematopoiesis in children with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leuk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

The administration of 10 microg/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilization with chemotherapy and hematopoietic growth factor failed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2004.03321.X

10.1111/J.0041-1132.2004.03321.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

15104662

1 reference

5 February 2018